mRNA 活跃 PI:PubMed 反推名单(广东 / 浙江)

不是立项名单,是已经在发论文的人。检索式:mRNA vaccine / mRNA therapeutic / mRNA delivery / lipid nanoparticle / LNP / circRNA / self-amplifying RNA / in vitro transcription + China[ad] + 2024–2025。通讯作者取末位作者,单位为末位作者单位。截至 2026-10-17。
中国机构论文
3,173
命中总 3,206 篇
广东
407 篇
139 家单位
浙江
246 篇
110 家单位
带国自然批准号
541 篇
可回填官方立项库

广东:单位 Top 12

单位论文数PI 数国自然号数
Sun Yat-sen University736057
Southern Medical University443821
Guangzhou Medical University21187
South China Agricultural University16124
Southern University of Science and Technology14115
Jinan University1081
Fudan University10910
The First Affiliated Hospital of Guangzhou Medical University1094
Sun Yat-sen University Cancer Center986
Chinese Academy of Sciences881
Affiliated Hospital of Guangdong Medical University850
Shenzhen Campus of Sun Yat-sen University653

广东:活跃 PI Top 20

单位通讯作者论文数国自然批准号代表论文
Liverna Therapeutics Inc.Peng Yucai5—Herpes zoster mRNA vaccine elicits superior immune responses over lice
Southern Medical UniversityChen Rufu4—RBMS1-mediates the biogenesis of circNFIB promotes perineural invasion
Sun Yat-sen UniversityChen Jinjin4—Pancreas-targeted lipid nanoparticles for relatively non-invasive inte
Southern University of Science and TechnologyZeng Chen382402147Glycolipids Substitute PEG lipids in Lipid Nanoparticles for mRNA Deli
Sun Yat-sen UniversityChen Yongming382341037Exaggerated Lung Inflammation Induced by Lung-Targeted mRNA-LNP Dampen
Sun Yat-sen UniversityXie Zhi3—Deep generative optimization of mRNA codon sequences for enhanced mRNA
Guangzhou Medical UniversityChen Wenjie3—A leucine derivate-adjuvanted LNP vaccine enhances antitumor immunity
Affiliated Hospital of Guangdong Medical UniversityWu Dong3—circ-0001875 downregulation is associated with M1 macrophage activatio
Sun Yat-sen UniversityYao Shuzhong3—Differentially expressed circular RNA profiles and comprehensive analy
Shenzhen Polytechnic UniversityXu Lei261872114/61922020/62131004/62201129/62231013/62271329/62302341/62303328/62372332CircRNA identification and feature interpretability analysis.
The First Affiliated Hospital of Jinan UniversityLu Dan281671167/81801150/81971121/82171316/82271304/82301465IGF2BP1 positively regulates CircOGDH accumulation in hypoxia induced
Southern Medical UniversityZhu Bofeng281930055/82160325/82360336Forensic stability evaluation of selected miRNA and circRNA markers in
Sun Yat-sen UniversityPang Jun232400649/82272689Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through AD
Sun Yat-sen UniversityYu Dongsheng281974146/82373255CircAars-Engineered ADSCs Facilitate Maxillofacial Bone Defects Repair
South China Agricultural UniversityChen Ting232372958CircLSM14A regulates PEDV replication via the miR-27b-5p/HMGB1 axis.
Guangzhou Medical UniversityZhang Qiong282402135Developing an eVLP mRNA vaccine for respiratory syncytial virus with e
Jinan UniversityLi Bin282072053Ocular delivery of lipid nanoparticles-formulated mRNA encoding lanost
Southern University of Science and TechnologyWang Zefeng2—Circular RNA encoding relaxin-2 as a potential therapy for liver fibro
Shenzhen Campus of Sun Yat-sen UniversityDeng Guanjun2—mRNA vaccine developed for sequential selective organ-to-cell targetin
Affiliated Hospital of Guangdong Medical UniversityWang Peng2—CircAASS alleviates renal injury and fibrosis by regulating mitochondr

浙江:单位 Top 12

单位论文数PI 数国自然号数
Zhejiang University41273
Zhejiang University School of Medicine252315
Ningbo University15124
Wenzhou Medical University760
Hangzhou Medical College652
The Third Affiliated Hospital of Soochow University651
The First Affiliated Hospital of Ningbo University660
The First Affiliated Hospital of Wenzhou Medical University550
Zhejiang Shuren University551
Zhejiang Cancer Hospital431
Westlake University440
The Affiliated Lihuili Hospital of Ningbo University331

浙江:活跃 PI Top 20

单位通讯作者论文数国自然批准号代表论文
Zhejiang UniversityLiu Shuai1032471375Artificial intelligence-guided design of lipid nanoparticles for mRNA
Zhejiang UniversityTang Jianbin3—Hydroxychloroquine-Derived Ionizable Lipid Facilitates Spleen-Tropic T
Zhejiang University of TechnologyYan Yunfeng3—Development of Diselenide-Containing Poly(β-amino ester)s for Potent m
Nucleic Acid Medicine Innovation CenterYang Yongsheng3—A bivalent mRNA vaccine against RSV infection in rodent models.
Hangzhou City UniversityDuan Shiwei3—Unraveling the role of miR-767 in tumor progression: Mechanisms and cl
Zhejiang University School of MedicineLu Zhimin282030074/82188102Inhibition of Tumor Lipogenesis and Growth by Peptide-Based Targeting
Ningbo UniversityLi Chenghua232273164/32325050Vibrio splendidus infection promotes circRNA-FGL1-regulated coelomocyt
Ningbo UniversityMeng Xiaodan281902146Exosomal circ_0008803 drives lung cancer cell migration and invasion v
Zhejiang University School of MedicineSong Zhangfa282273265Exosomes containing circSCP2 in colorectal cancer promote metastasis v
Hangzhou Medical CollegeWang Youru2—A single ultra-low dose self-amplifying RNA rabies vaccine confers rap
Zhejiang Cancer HospitalTan Weihong2—Intraperitoneal programming of tailored CAR macrophages via mRNA lipid
Zhejiang UniversityLuo Jindan2—The roles and function of circular RNA in prostate cancer.
Wenzhou Medical UniversityHiguchi Akon2—Development of lyophilized mRNA-LNPs with high stability and transfect
Zhejiang UniversityHu Fuqiang2—Oleic Acid-Shelled Solid Lipid Nanocomplexes for Enhanced Quercetin De
Ningbo No.2 HospitalZhu Peng2—Development and Evaluation of a Droplet Digital PCR Assay for the Accu
Hangzhou Normal UniversityXie Tian2—The anti-metastatic effect of elemene in human hepatocellular carcinom
The Third Affiliated Hospital of Soochow UniversityShao Yingjie2—m6A-modified circCREBBP enhances radiosensitivity of esophageal squamo
Ningbo UniversityZhang Lina2—Construction of Immune-Related circRNA-miRNA-mRNA Network and Identifi
Zhejiang UniversityYou Jian2—Pharmaceutical strategies for optimized mRNA expression.
Eye Center of Second Affiliated HospitalFu Qiuli181300641/81670833/81870641/82070939/82271063/82471054Corneal biomechanical cues mediated by PAI-2: the origin of PM2.5-indu

怎么用 / 局限

  • 用法:这份名单是“现在就在做 mRNA 的实验室”,比立项名单更接近真实采购;国自然批准号可直接与官方导出对撞,验证是否为 2026 立项。
  • 局限 1:末位作者≈通讯作者,但不绝对;个别论文通讯作者非末位。
  • 局限 2:只有发过论文的 PI,新立项还没发文的人不在名单里。
  • 局限 3:单位取末位作者单位,合作论文可能归错单位。
  • 局限 4:只覆盖 2024–2025 英文论文,中文期刊与会议不在内。
__FOOTER__